White & Case hires Alex Zhang as head of M&A in China

Zhang has more than 20 years of experience in advising international and domestic clients on China business, which included work on the sales of CITIC Pharmaceutical and China Health System to Shanghai Pharmaceutical, touted as the largest M&A transaction to date in the country's pharmaceutical product sector.

At Jones Day, Zhang focused on areas ranging from M&A to venture capital and private equity financing to Asia distressed asset transactions, and coordinated the firm's China investments practice. Prior to joining the firm, he served as the co-chair of Dorsey & Whitney's Asia practice, also based out of Shanghai.

"Clients are increasingly expecting the international firms in China to have senior Mandarin-speaking lawyers with strong international experience leading their M&A transactions," Xiaoming Li, head of White & Case's China practice, said in a statement. "Mr Zhang, having worked in the US, Hong Kong and China, adds considerable strength to our growing China team at a very senior level."

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Greater China
• People
• China
• Appointments
• M&A
• White & Case